Frequently Asked Questions
Is this study only for females with CT and GC?
Yes, this study is focused on females with CT and GC. If you are a male and would like to participate in any future studies for males, feel free to contact us to let us know that you are interested in future studies.
What if I am not sure about my CT or GC diagnosis?
It would be best for you to see your doctor for a clear CT or GC diagnosis. If there is a diagnosis, ask your doctor for a copy of your diagnosis. The documentation will help our study team proceed with the potential enrollment process.
What if I am already getting treatment for my CT or GC diagnosis would I still qualify?
If you are getting the standard of care treatment for CT or GC we will ask that you continue your treatment as directed. You will be eligible to enroll 14 days after the last treatment of your medication.
How long will the study last?
The study will take approximately 20 weeks to complete.
What does a typical visit consist of?
If you meet all the criteria for the study, you will complete an intial visit, which will consist of the consenting of the study (which explains the purpose of this research study, procedures, benefits, risks, and precautions), a test for current GC/CT infection by NAAT (vaginal swab), and the dispensing of study product. Visits will occur ever 4 weeks (5 visits total), during these visits we will ask you to complete a urine pregnancy test, review your electronic diary, document the unused and used product, and dispense you the new product.
Do I have to pay to participate in the Sensitive Study?
Will I be paid for taking part and/or reimbursed for travel?
What is a clinical Trial?
What is an investigational study medication?
Who oversees my clinical research information?
Who can I talk to about this research study?
Call 409-867-5309 if you have any questions. Our staff will be available to answer any of the questions you may have about the Sensitive Study.
Will I know if I will be on the investigational medication or placebo while I am in the study?
This is a blinded study, which means that this study is done in such a way that the participant does not know (is blinded as to) what treatment they are receiving to elimate or reduce biases until the trial outcome is known.